Literature DB >> 19879034

[Incidence of bronchopulmonary cancer in Castilla y Leon and Cantabria in the year 2007. A study by the Castilla y Leon and Cantabria Respiratory Diseases Society (SOCALPAR)].

Jesús R Hernández-Hernández1, Félix Heras-Gómez, María Rosa Cordovilla-Pérez, Teresa Antolín-García, Elena Bollo De Miguel.   

Abstract

INTRODUCTION: This study sets out to find out the incidence and other epidemiological characteristics of bronchopulmonary cancer in patients living in Cantabria and Castilla y Leon (Spain) and comparing the current data obtained in the last communities with that obtained 10 years ago in a similar study. PATIENTS AND METHODS: Prospective, multicentre study using information (age, sex, residence, smoking habits and histology) obtained from all patients diagnosed during the year 2007.
RESULTS: A total of 1486 patients were included--1295 males (87.1%) and 191 females (12.9%)--, of whom 1145 lived in Castilla y Leon--1010 males (88.2%) and 135 females (11.8%)--, and 341 in Cantabria--285 males (83.6%) and 56 females (16.4%)--. The incidence rates per 100,000 inhabitants adjusted to the world standard population were significantly higher in Cantabria [29.53; (males: 52.9; females: 9.76)] than in Castilla y Leon [21.35; (males: 38.31; females: 5.58)]. A total of 90.24% were smokers (males: 96.12% and women: 49.17%). The main histology types were: squamous, 32, 82%; adenocarcinoma, 28.74%, and small cell carcinomas, 18.33%. In Castilla y Leon, from 1997 to 2007, the numbers went from 920 to 1010 in males and from 95 to 135 in females (a crude rate increase of 10.5% in males and 43% in females), and showed a decrease in squamous tumours and an increase in adenocarcinomas.
CONCLUSIONS: The incidence rates of bronchopulmonary cancer in 2007 were significantly higher in Cantabria than those of Castilla y Leon. The 2007 rates in this community were higher than in 1997 in both males and females. Copyright (c) 2009 SEPAR. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19879034     DOI: 10.1016/j.arbres.2009.09.010

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  2 in total

1.  GATA6 Exerts Potent Lung Cancer Suppressive Function by Inducing Cell Senescence.

Authors:  Wensheng Chen; Zhipeng Chen; Miaomiao Zhang; Yahui Tian; Lu Liu; Ruirui Lan; Guandi Zeng; Xiaolong Fu; Guoqing Ru; Wanting Liu; Liang Chen; Zhenzhen Fan
Journal:  Front Oncol       Date:  2020-06-12       Impact factor: 6.244

2.  [Smoking intervention in patients with cardiovascular diseases].

Authors:  José Ignacio de Granda-Orive; Segismundo Solano-Reina; Carlos Andrés Jiménez-Ruiz
Journal:  Aten Primaria       Date:  2012-03-10       Impact factor: 1.137

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.